IE32140L - Vaccine - Google Patents
VaccineInfo
- Publication number
- IE32140L IE32140L IE680713A IE71368A IE32140L IE 32140 L IE32140 L IE 32140L IE 680713 A IE680713 A IE 680713A IE 71368 A IE71368 A IE 71368A IE 32140 L IE32140 L IE 32140L
- Authority
- IE
- Ireland
- Prior art keywords
- informationally
- viruses
- antigen
- influenza
- vaccines
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241000700605 Viruses Species 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000007900 aqueous suspension Substances 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 206010022000 influenza Diseases 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000588807 Bordetella Species 0.000 abstract 1
- 241000282465 Canis Species 0.000 abstract 1
- 102000016607 Diphtheria Toxin Human genes 0.000 abstract 1
- 108010053187 Diphtheria Toxin Proteins 0.000 abstract 1
- 208000000655 Distemper Diseases 0.000 abstract 1
- 241000991587 Enterovirus C Species 0.000 abstract 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 abstract 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 abstract 1
- 201000005505 Measles Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 206010037742 Rabies Diseases 0.000 abstract 1
- 241000282898 Sus scrofa Species 0.000 abstract 1
- 206010043376 Tetanus Diseases 0.000 abstract 1
- 108010055044 Tetanus Toxin Proteins 0.000 abstract 1
- 241000700647 Variola virus Species 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 abstract 1
- 229940001007 aluminium phosphate Drugs 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 210000004671 cell-free system Anatomy 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 206010014599 encephalitis Diseases 0.000 abstract 1
- 210000000416 exudates and transudate Anatomy 0.000 abstract 1
- 208000006454 hepatitis Diseases 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 210000002751 lymph Anatomy 0.000 abstract 1
- 210000001165 lymph node Anatomy 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229920002477 rna polymer Polymers 0.000 abstract 1
- 239000003998 snake venom Substances 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
1,229,888. Vaccines. D. JACHERTZ. 19 June, 1968 [19 June, 1967], No. 29232/68. Heading A5B. Vaccines which are antigen-free and comprise aqueous suspensions of informationally active ribonucleic acid are prepared by stimulating with an antigen corresponding to the required informationally active RNA as system of immunologically competent cells or a cellfree system obtained therefrom, and isolating an aqueous suspension of the informationally active RNA. The vaccine may also contain an adjuvant such as aluminium hydroxide or phosphate and/or a pharmaceutically suitable carrier. The immunologically competent cells may be from human or animal lymphs, lymph nodes, spleen, peritoneal exudates and pheripheral leukocytes (blood). The antigen used may be from bacteria, viruses or their subunits or snake poison, e.g. tetanus and diphtheria toxin; the products of metabolism or degradation of Bordetella pertussio, Mycobacterlium tuberculosis, salmonellae, shigellae, brucellae; influenza, influenza haemagglutinim, polio viruses or their protein envelope, measles, rabies, foot and mouth disease, smallpox, swine fever, distemper, hepatitis contagiosa canis and encephalitis viruses.
[GB1229888A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEJ0033936 | 1967-06-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE32140L true IE32140L (en) | 1968-12-19 |
| IE32140B1 IE32140B1 (en) | 1973-04-18 |
Family
ID=7204943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE713/68A IE32140B1 (en) | 1967-06-19 | 1968-06-17 | Vaccines |
Country Status (13)
| Country | Link |
|---|---|
| AT (1) | AT282821B (en) |
| BE (1) | BE716806A (en) |
| BR (1) | BR6899970D0 (en) |
| CH (1) | CH513241A (en) |
| DE (1) | DE1617545C2 (en) |
| DK (1) | DK119724B (en) |
| ES (1) | ES355121A1 (en) |
| FR (2) | FR1588820A (en) |
| GB (1) | GB1229888A (en) |
| IE (1) | IE32140B1 (en) |
| IL (1) | IL30168A (en) |
| NL (1) | NL6808486A (en) |
| NO (1) | NO124840B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754934A (en) * | 1969-08-16 | 1971-02-17 | Jachertz Diether | RNA-MESSENGER ENZYMATIC PRODUCTION PROCESS |
| GB1594097A (en) | 1976-12-16 | 1981-07-30 | Int Inst Of Differentiation | Production of specific immune nucleic acids cell dialysates and antibodies |
| DE3115559A1 (en) * | 1981-04-16 | 1982-10-28 | Kommanditgesellschaft Schwarzhaupt, 5000 Köln | HIGH PURIFIED INFORMATIVE RIBONUCLEIC ACID (I-RNS), METHOD FOR THE PRODUCTION AND USE THEREOF |
| GB2216416B (en) * | 1988-03-11 | 1992-06-24 | Sandoz Ltd | Nucleobase source for the stimulation of the immune system |
| US6867195B1 (en) | 1989-03-21 | 2005-03-15 | Vical Incorporated | Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected |
| US6673776B1 (en) | 1989-03-21 | 2004-01-06 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US6214804B1 (en) | 1989-03-21 | 2001-04-10 | Vical Incorporated | Induction of a protective immune response in a mammal by injecting a DNA sequence |
-
1967
- 1967-06-19 DE DE1617545A patent/DE1617545C2/en not_active Expired
-
1968
- 1968-06-12 IL IL30168A patent/IL30168A/en unknown
- 1968-06-15 NO NO2340/68A patent/NO124840B/no unknown
- 1968-06-17 CH CH893668A patent/CH513241A/en not_active IP Right Cessation
- 1968-06-17 IE IE713/68A patent/IE32140B1/en unknown
- 1968-06-17 NL NL6808486A patent/NL6808486A/xx unknown
- 1968-06-17 AT AT576668A patent/AT282821B/en not_active IP Right Cessation
- 1968-06-18 DK DK286268AA patent/DK119724B/en unknown
- 1968-06-18 ES ES355121A patent/ES355121A1/en not_active Expired
- 1968-06-19 BE BE716806D patent/BE716806A/xx unknown
- 1968-06-19 FR FR1588820D patent/FR1588820A/fr not_active Expired
- 1968-06-19 BR BR199970/68A patent/BR6899970D0/en unknown
- 1968-06-19 GB GB1229888D patent/GB1229888A/en not_active Expired
- 1968-09-18 FR FR166589A patent/FR7781M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR7781M (en) | 1970-03-23 |
| DE1617545A1 (en) | 1971-04-01 |
| DE1617545C2 (en) | 1983-11-03 |
| IL30168A0 (en) | 1968-08-22 |
| BR6899970D0 (en) | 1973-02-13 |
| ES355121A1 (en) | 1969-11-16 |
| AT282821B (en) | 1970-07-10 |
| FR1588820A (en) | 1970-03-16 |
| IE32140B1 (en) | 1973-04-18 |
| IL30168A (en) | 1973-05-31 |
| NO124840B (en) | 1972-06-12 |
| CH513241A (en) | 1971-09-30 |
| BE716806A (en) | 1968-12-19 |
| NL6808486A (en) | 1968-12-20 |
| DK119724B (en) | 1971-02-15 |
| GB1229888A (en) | 1971-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Milich | Synthetic T and B cell recognition sites: implications for vaccine development | |
| Wiktor et al. | Cultivation of rabies virus in human diploid cell strain WI-38 | |
| Oxford et al. | The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection | |
| Mumford et al. | Studies with inactivated equine influenza vaccine: 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8) | |
| Sundquist et al. | Influenza virus ISCOMs: antibody response in animals | |
| Zygraich et al. | In vivo and in vitro properties of a temperature sensitive mutant of infectious bovine rhinotracheitis virus | |
| Webster et al. | Potentiation of the immune response to influenza virus subunit vaccines | |
| US3959466A (en) | Highly attenuated cytomegalovirus vaccine and production thereof | |
| JP2011525902A (en) | Rapid response to delayed boost immunization | |
| IE32140B1 (en) | Vaccines | |
| Atanasiu et al. | Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons: Part 3 | |
| US3927208A (en) | Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them | |
| Glasgow et al. | Isoprinosine: lack of antiviral activity in experimental model infections | |
| JPH05501401A (en) | Vaccine or toxoid preparations and immunization methods by metastatic growth with recombinant microorganisms | |
| Reiss et al. | Specificity of the helper T cell for the cytolytic T lymphocyte response to influenza viruses | |
| Holper et al. | Further studies on multiplication, serology and antigenicity of 2060 and JH viruses | |
| Norrby et al. | Humoral immunity to canine distemper after immunization of dogs with inactivated and live measles virus | |
| Barbour et al. | Comparison of Mycoplasma gallisepticum subunit and whole organism vaccines containing different adjuvants by western immunoblotting | |
| Laver et al. | Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine | |
| US3629413A (en) | Polyvalent bovine vaccines and methods of making and using same | |
| US5006335A (en) | Live vaccine against mumps and process for obtaining thereof | |
| Millian et al. | Antibody response of man to canine distemper virus | |
| McLaren et al. | Immunity to influenza in ferrets: XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization | |
| Srivastava et al. | Studies on the immunogenicity of Streptococcus equi vaccines in foals | |
| Musser et al. | Production of rubella virus vaccine: Live, attenuated in canine renal cell cultures |